To examine whether the presence of pre-pacing functional mitral regurgitation (MR) and its improvement would affect the extent of left ventricular (LV) reverse remodelling after cardiac resynchronization therapy (CRT).
Introduction
Cardiac resynchronization therapy (CRT) is an established therapy for patients with advanced chronic heart failure with prolonged QRS duration. Clinical data have suggested the beneficial role of CRT on symptoms, functional capacity, 1 -3 cardiac function, 4, 5 and prognosis. 6 -8 On cardiac functional assessment, apart from evidence of improvement in systolic function leading to left ventricular (LV) reverse remodelling, improvement of functional mitral regurgitation (MR) has been described in previous studies. 9 -14 In fact, MR could be an important component underlying the favourable haemodynamic changes and gain in systolic function due to volume unloading effect in the LV and pressure offload in the left atrium (LA). 15, 16 Nonetheless, whether the presence of pre-pacing functional MR and its improvement might have impacted on LV reverse remodelling and gain in systolic function has not been explored. Furthermore, the occurrence of systolic MR is actually a complex condition which has phasic components, namely early-systolic MR which starts from the isovolumic contraction period and late-systolic MR. 17 These two phases of MR may respond differently after CRT and their impacts on LV reverse remodelling could be different. Therefore, the objective of the present study was to examine whether the presence of pre-pacing functional MR and its improvement would affect the extent of LV reverse remodelling and gain in ejection fraction after CRT. In addition, the relative contribution of early-and late-systolic MR in predicting CRT response was evaluated.
Methods Patients
Between January 2005 and March 2008, 83 patients were prospectively recruited from the consecutive 90 patients who received CRT implantation and were followed up for at least 3 months. The inclusion criteria for receiving CRT were compatible with the current guideline, i.e. evidence of systolic dysfunction with LV ejection fraction ≤35% despite optimal medical therapy, New York Heart Association (NYHA) class III or IV, and QRS duration .120 ms. Those patients who had morphological abnormalities of the mitral valve apparatus, clinical or echocardiographic evidence of other structural cardiac diseases (such as valvular, pericardial, congenital, or infiltrative heart disease), atrial flutter or fibrillation, and greater than mild aortic regurgitation were excluded. Among the 83 patients, 48 patients had more than mild functional MR before device implantation and 35 patients had only mild or no functional MR screened by Doppler echocardiography with details as follows. 18 The study protocol was approved by the Ethics Committee of the institution and written informed consents were obtained from all the patients.
Clinical assessment
In addition to echocardiographic evaluation, the assessment of clinical status was also performed at baseline and 3 months after CRT, which included NYHA functional class and Minnesota Living With Heart Failure (MLWHF) quality of life score.
Echocardiography
Transthoracic echocardiography was performed (Vivid 7, Vingmed-General Electric, Horton, Norway) before and 3 months after CRT implantation. The images were stored digitally for offline analysis (EchoPac PC 7.0.0, Vingmed-General Electric). At least three consecutive beats were measured and the average value was obtained. Left ventricular end-diastolic volume (LVEDV), LV end-systolic volume (LVESV), and ejection fraction were calculated from the apical four-and two-chamber views, using biplane Simpson's method. Left ventricular forward stroke volume was calculated as the product of the crosssectional area and the time-velocity integral of the LV outflow tract. In the apical four-chamber view, the LV end-systolic and end-diastolic cavity length and mid-cavity width were measured. The LV end-systolic and end-diastolic sphericity indices were estimated by the ratio of LV length to width for the assessment of the change in LV geometry. 19 At 3 months after CRT, patients with a reduction in LVESV of ≥15% were defined as responders of LV reverse remodelling.
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The ratio of MR jet area to LA area was measured as a quick screening of MR severity at baseline, with more than mild MR defined as the ratio ≥20%, whereas mild or no functional MR as the ratio ,20%. In those patients with more than mild MR at baseline, further quantification of MR was performed before and after device implantation, including overall MR as well as its early-and late-systolic components. The severity of overall MR was measured by the total MR volume using the quantitative Doppler method as described previously.
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The early-and late-systolic components of MR were assessed by the instantaneous MR flow rate at early-and late-systole using the proximal isovelocity surface area method. 23 The dynamic change in the severity of MR was calculated by frame-by-frame analysis throughout the regurgitant period from mitral valve opening to mitral valve closure where the first and last one-third was defined as early-and late-systole, respectively. The images at the timing of the maximum proximal flow convergence area at early-and late-systole were selected for assessing the instantaneous MR flow rate.
Statistical analyses
The statistical analyses were performed by using a commercial software (SPSS for windows, version 13.0, SPSS Inc., Chicago, IL, USA). Continuous variables are expressed as mean + SD. Categorical data are summarized as frequencies and percentages. Paired t-test or Wilcoxon's signed-rank test was used when appropriate to compare between baseline and after CRT. ANOVA or Pearson's x 2 test was used when appropriate to compare among the three groups of patients who had MR improvement after CRT, had no MR improvement after CRT, and had only mild or no MR at baseline. Receiveroperating characteristic (ROC) curve was analysed to evaluate the contribution of improvement in functional MR to LV reverse remodelling. All the tests performed were two-sided where a P-value ,0.05 was considered statistically significant.
Results
Left ventricular reverse remodelling and clinical response after cardiac resynchronization therapy
The baseline characteristics of the patients are described in Table 1 . At 3 months after CRT implantation, LV reverse remodelling was achieved by the reduction of LVEDV and LVESV, as well as gain in ejection fraction and forward stroke volume (all P , 0.001). By using the reduction of LVESV ≥ 15%, 45 out of the 83 patients (54%) were found to be volumetric responders, whereas the other 38 were non-responders ( Table 2) . Improvement of LV geometry was achieved by a greater extent of decrease in the LV width (P , 0.001 both at end-systole and end-diastole) than the length (end-systolic, P ¼ 0.032; end-diastolic, P ¼ 0.028) which resulted in a higher sphericity index (end-systolic, P ¼ 0.007; end-diastolic, P ¼ 0.002), i.e. a less globular shape of LV. Furthermore, clinical status was significantly improved, which included an NYHA class (P , 0.001) and MLWHF quality of life score (P ¼ 0.015) ( Table 2) . However, these favourable changes were mainly observed in responders but not in non-responders, though the demographics between the two groups were comparable at baseline except that responders had more female patients (Tables 1 and 2 ).
Changes in functional mitral regurgitation and its components after cardiac resynchronization therapy
In the 48 patients who had more than mild MR before device implantation, the total MR volume decreased significantly (38 + From the ROC curve, the reduction in total MR volume of 11% was found to be associated with a significant LV reverse remodelling with a sensitivity of 90% and a specificity of 80% [area under the curve (AUC) ¼ 0.85, P , 0.001]. Similarly, the reduction in early-systolic MR flow rate of 10% was associated with LV reverse remodelling with a sensitivity and a specificity of 95 and 84%, respectively (AUC ¼ 0.88, P , 0.001), whereas the reduction in late-systolic MR flow rate of 11% gave rise to a lower sensitivity of 75% and specificity of 54% (AUC ¼ 0.74, P ¼ 0.004) (Figure 1 ).
Improvement in functional mitral regurgitation and left ventricular reverse remodelling
By using the cut-off of ≥11% reduction in total MR volume at 3 months after CRT, the 48 patients with more than mild functional Improvement of functional MR and CRT response MR at baseline were divided into two groups, i.e. the patients with improvement in total MR (Group 1, n ¼ 23) and those without (Group 2, n ¼ 25). Despite no differences in baseline total MR volume and early-and late-systolic MR flow rate, Group 1 showed a reduction of all the three parameters by 239% (P , 0.001), 239% (P , 0.001), and 241% (P ¼ 0.004), respectively, after CRT. On the other hand, Group 2 showed a significant increase in late-systolic MR flow rate by 7% (P ¼ 0.024) without changes in total MR volume and early-systolic MR flow rate. In addition, the 35 patients with mild or no functional MR at baseline were classified into Group 3. Although the LV volumes at baseline were relatively larger in Groups 1 and 2, the LV ejection fraction and forward stroke volume were comparable among the three groups. At 3 months after CRT, all the three groups showed improvement in LVESV and ejection fraction, whereas the reduction in LVEDV and improvement of forward stroke volume were not observed in Group 2 ( Table 3) . Furthermore, the magnitude of LV reverse remodelling was different among the three groups when assessed by absolute and percentage changes in LVESV after CRT. Interestingly, the greatest reduction in LVESV was found in Group 1 (236 + 17 mL or 229.8 + 12.0%), the least in Group 2 (28 + 14 mL or 25.5 + 8.6%), and intermediate in Group 3 (219 + 19 mL or 218.6 + 16.6%) (P , 0.001) (Figure 2A) . Similarly, Group 1 showed the greatest gain in LV ejection fraction (11.8 + 6.2%) and forward stroke volume (43.1 + 37.9%), which was followed by Group 3 (7.0 + 6.8 and 21.1 + 26.1%), and was the least in the Group 2 (3.0 + 5.0 and 6.8 + 34.6%) (LV ejection fraction, P , 0.001; forward stroke volume, P ¼ 0.001) ( Figures 2B  and C, 3-5) . Accordingly, the responder rate was the highest in Group 1 (91%), intermediate in Group 3 (54%), and the lowest in Group 2 (20%) (x 2 ¼ 24.54, P , 0.001). With respect to the changes in LV geometry, both end-systolic and end-diastolic sphericity indices were increased in Group 1, whereas only end-systolic sphericity index was increased in Group 3, but neither of them were in Group 2 after CRT ( Table 3) . For baseline clinical status, the NYHA class and quality of life score were similar among the three groups. At 3 months after CRT, NYHA class was significantly improved in all the three groups, although the improvement of quality of life score was only observed in Groups 1 and 3, but not in Group 2 ( Table 3 ).
Discussion
The current study has the following new observations with respect to functional MR and CRT. First, CRT improved both early-and late-systolic MR in advanced heart failure patients. Secondly, LV reverse remodelling with gain in LV ejection fraction and forward stroke volume occurred to the greatest extent in patients who showed improvement of functional MR, was intermediate in those without pre-pacing MR, and was the least in patients without significant improvement of MR. As a result, the prevalence of volumetric responders to CRT also followed the same order.
A number of methods have been used to characterize CRT responses in terms of acute haemodynamic, mid-or long-term clinical and echocardiographic variables. In the present study, LV reverse remodelling assessed by two-dimensional echocardiography was being chosen as it could be measured in a blinded manner and less subjective to placebo effect than clinical parameters. Furthermore, the occurrence of early LV reverse remodelling after CRT has been observed to predict favourable long-term prognosis. 24, 25 The definition of responder by a reduction in LVESV ≥ 15% was a relatively stringent criterion, which might result in the relatively higher non-responder rate compared with other reports using different parameters. In patients with functional MR where the calculation of LV ejection fraction is based on the blood ejected into both the aorta and the LA during systole, the change in ejection fraction after CRT is partly affected by the change in MR. If MR disappears, LV ejection fraction may remain unchanged where the total amount of blood ejected is not increased; however, the forward stroke volume into the aorta would have been increased. Therefore, forward stroke volume was also measured as a parameter of functional improvement after CRT in the present study apart from LV ejection fraction and LVESV, all of which followed the same trend of changes among the three patient groups. Regarding the quantification of MR severity, there has been a relative lack of consensus on the best echocardiographic method while multi-methodological approach has been suggested. In the current study, the proxim isovelocity surface area method was adopted for assessing earlyand late-systolic MR flow rate, whereas quantitative Doppler method was used for computing total MR volume. Although the Doppler volumetric method is a recognized non-invasive measurement for MR, it may overestimate regurgitant volume and effective regurgitant orifice due to the geometrical assumption of mitral annulus. 22 However, this systematic error might occur in every subject evaluated, and therefore, the impact could have been minimized when compared among the three patient groups by the use of appropriate statistics. Although the improvement of functional MR after CRT has been described in previous studies, 10 its impact on LV reverse remodelling has not been explored. The present study illustrated that the improvement of functional MR was an important contributor to LV reverse remodelling which occurred at 3 months after CRT. The extent of LV reverse remodelling (measured by reduction of LVESV) was more than five-fold different in patients with and without significant improvement of pre-pacing MR (229.5 vs. 25.5%). Consequently, the prevalence of volumetric responders was more than four-fold different between the two groups (91 vs. 20%). Interestingly, patients without significant prepacing MR showed intermediate response for the extent of reduction in LVESV and the prevalence of volumetric responders. Therefore, it appears that the status of functional MR plays a pivotal role in determining CRT response. Nevertheless, the follow-up period was relatively short, which was a limitation of the current study. It warrants further investigations in a larger study population with longer follow-up. In heart failure patients, functional MR could have been caused by a few major factors, namely failure of mitral leaflet coaptation due to mid-cavity dilatation, regional displacement of papillary apparatus resulting in incomplete coaptation, and LV dysfunction resulting in poor coaptation force. 26 -29 In the presence of wide QRS complexes, MR could have been worsened by the dyssynchrony of LV or papillary muscle attaching sites that dissipates contractile force and distorts mitral apparatus geometry by uncoordinated regional contraction. 30, 31 Understandably, the former factor may worsen both early-and late-systolic MR, whereas the impact of dyssynchrony on different phase of MR remains to be determined, although it has been suggested that the late-systolic component is more likely to be worsened by enhanced local remodelling caused by dyssynchrony. 32 Of note, the presence of functional MR per se could have worsened LV volumetric overload and exacerbate LA pressure and volume overload, which would set up a vicious cycle that accelerates LV remodelling and deterioration of systolic function. Therefore, when patients responded to CRT and developed a more synchronous timing of LV contraction, the LV would show initial response by improving the forward systolic force and increasing ejection fraction. In the subset of patients who also have co-existing functional MR, the beneficial effect will be augmented through additional reduction of MR by the following reasons: a stronger mitral valve coaptation force development that reduces early-systolic MR 13 as well as improved synchronicity of the papillary muscles and the nearby LV wall leading to reduction of both earlyand late-systolic MR. 9 -12 When initial LV reverse remodelling is achieved, the favourable improvement of LV geometry with decrease in LV mid-cavity dilatation will further alleviate the amount of restrictive mitral leaflet movement during systole. As a result, a positive feedback mechanism will be established which contributes further LV reverse remodelling and reduction of functional MR.
Conclusion
The observations in the present study indicate that CRT improves functional MR by reducing its early-and late-systolic components. Both the early-and late-systolic MR contribute to LV reverse remodelling after CRT. However, CRT predominately improves early-rather than late-systolic MR, which also appears to be an important contributor to CRT response.
